These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 736748)
41. Subrenal capsule assay of fresh human tumors: problems and pitfalls. Abrams J; Jacobovitz D; Dumont P; Semal P; Mommen P; Klastersky J; Atassi G Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1387-94. PubMed ID: 3030761 [TBL] [Abstract][Full Text] [Related]
42. "Send this patient's tumor for culture and sensitivity". Von Hoff DD N Engl J Med; 1983 Jan; 308(3):154-5. PubMed ID: 6336821 [No Abstract] [Full Text] [Related]
43. Individualized patient chemotherapy: use of a human tumor colony formation technique. Meyskens FL Front Radiat Ther Oncol; 1981; 16():55-61. PubMed ID: 7199500 [No Abstract] [Full Text] [Related]
44. Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. Wheeler TK; Dendy PP; Dawson A Oncology; 1974; 30(5):362-76. PubMed ID: 4462060 [TBL] [Abstract][Full Text] [Related]
45. Developing new drugs for ovarian cancer: a challenging task in a changing reality. Canetta RM; Carter SK J Cancer Res Clin Oncol; 1984; 107(2):111-24. PubMed ID: 6371015 [TBL] [Abstract][Full Text] [Related]
46. Predicting response of human solid tumors to chemotherapy. Tanneberger S; Nissen E Cancer Treat Rev; 1983 Dec; 10(4):203-19. PubMed ID: 6362872 [No Abstract] [Full Text] [Related]
47. Biochemical short-term predictive assay: results of correlative trials in comparison to other assays. Kaufmann M Recent Results Cancer Res; 1984; 94():151-60. PubMed ID: 6387831 [No Abstract] [Full Text] [Related]
48. Clinical relevance of predictive tests for cancer chemotherapy. Mattern J; Volm M Cancer Treat Rev; 1982 Dec; 9(4):267-98. PubMed ID: 6762922 [No Abstract] [Full Text] [Related]
49. Clonogenic assays for the chemotherapeutic sensitivity of human tumours. Lancet; 1982 Apr; 1(8275):780-1. PubMed ID: 6121231 [No Abstract] [Full Text] [Related]
50. [Two years of experience with in-vitro testing of malignant ovarian tumors (proceedings)]. Doerjer O; Teufel G; Pfleiderer A; Gräfe M; Schulz B Arch Gynakol; 1977 Jul; 224(1-4):358-9. PubMed ID: 579858 [No Abstract] [Full Text] [Related]
51. Specific and nonspecific macromolecule-drug conjugates for the improvement of cancer chemotherapy. Hurwitz E Biopolymers; 1983 Jan; 22(1):557-67. PubMed ID: 6201208 [No Abstract] [Full Text] [Related]
53. Pretherapeutic detection of tumour resistance and the results of tumour chemotherapy. Volm M; Wayss K; Kaufmann M; Mattern J Eur J Cancer (1965); 1979 Jul; 15(7):983-93. PubMed ID: 488156 [No Abstract] [Full Text] [Related]
55. Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Morgan D; Freshney RI; Darling JL; Thomas DG; Celik F Br J Cancer; 1983 Feb; 47(2):205-14. PubMed ID: 6297528 [TBL] [Abstract][Full Text] [Related]
56. Recent results of in vitro drug prediction in human tumour chemotherapy. Nissen E; Tanneberger S; Projan A; Morack G; Peek U Arch Geschwulstforsch; 1978; 48(7):667-72. PubMed ID: 736748 [TBL] [Abstract][Full Text] [Related]
57. Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance. Orr JW; Orr P; Kern DH Cancer J Sci Am; 1999; 5(3):174-8. PubMed ID: 10367175 [TBL] [Abstract][Full Text] [Related]
58. In vitro drug testing of ovarian cancer using the human tumor colony-forming assay: comparison of in vitro response and clinical outcome. Federico M; Alberts DS; Garcia DJ; Emerson J; Fanta P; Liu R; Salmon SE Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S156-63. PubMed ID: 7835801 [TBL] [Abstract][Full Text] [Related]
59. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma]. Trimbos JB; van der Burg ME Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388 [TBL] [Abstract][Full Text] [Related]